Pivotal trial of Teprotumumab in patients with Thyroid Eye Disease.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 16 May 2017
At a glance
- Drugs Teprotumumab (Primary)
- Indications Graves ophthalmopathy
- Focus Registrational; Therapeutic Use
- Sponsors Horizon Pharma
- 16 May 2017 New trial record
- 08 May 2017 According to a Horizon Pharma media release, this trial is expected to begin in Second Half of 2017.